Trump’s trade deal with the E.U. may lead to higher prices for brand-name drugs in the U.S., including Ozempic and Wegovy, ...

Tack on a half-dozen zeros to your CVS receipt and you'll get a sense of the sticker shock afflicting state officials, insurers and hospitals dealing with the soaring cost of prescription drugs in ...

In April, Danish drugmaker Novo Nordisk formed what was supposed to be a long-term collaboration to promote its weight-loss ...

Cosmetic surgeons are reporting a growing number of patients with sagging skin and facial hollowing after losing weight with ...

The Patients Deserve Price Tags Act, introduced by Sens. Roger Marshall and John Hickenlooper, would provide upfront price ...

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Pharmaceutical prices are expected to rise by 3.35% in 2026, according to Vizient’s latest Pharmacy Market Outlet report, released in July. The report found that price pressures are easing in certain ...

Medical supply chain costs are expected to rise by 2.41% in 2026, according to Vizient’s Summer 2025 Spend Management Outlook, released July 29. The increase will be driven by rising costs in IT ...

AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

A JAMA Network Open study reveals that patients with private insurance can face monthly costs nearing $600 after a cancer ...